Deciphering cryptic similarities in protein binding sites

Current Opinion in Biotechnology

Volumn 9, Issue 4, 1998, Pages 390-394

  Kauvar, Lawrence M ^a   Villar, Hugo O ^a  

^a Terrapin Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PROTEIN BINDING; DRUG TARGETING; GENETIC CONSERVATION; PRIORITY JOURNAL; PRODUCTIVITY; PROTEIN BINDING; PROTEIN STRUCTURE; REVIEW;

EID: 0032146156     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80013-X     Document Type: Article

References (45)

1. LaBella FS. Molecular basis for binding promiscuity of antagonist drugs. Biochem Pharmacol. 42:1991;51-58.
2. Kick EK, Roe DC, Skillman AG, Liu G, Ewing TJ, Sun Y, Kuntz ID, Ellman JA. Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem Biol. 4:1997;297-307.
3. Contreras JA, Karlsson M, Osterlund T, Laurell H, Svensson A, Holm C. Hormone-sensitive lipase is structurally related to acetylcholinesterase, bile salt-stimulated lipase, and several fungal lipases. J Biol Chem. 271:1996;31426-31430.
4. Sussman JL, Harel M, Frolow F, Defner C, Goldman A, Toker L, Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science. 253:1991;872-879.
5. Pearl L. Similarity of active site structures. Nature. 362:1993;24.
6. Kobayashi N, Go N. A method to search for similar protein local structures at ligand binding sites and its application to adenine recognition. Eur Biophys J. 26:1997;135-144.
7. Shi Y, Berg JM. A direct comparison of the properties of natural and designed zinc finger proteins. Chem Biol. 2:1995;83-89.
8. Moodie SL, Mitchell JBO, Thornton JM. Pattern recognition of adenylate: an example of a fuzzy recognition template. J Mol Biol. 263:1996;486-500.
9. Villar HO, Kauvar LM. Amino acid preferences at protein binding sites. FEBS Lett. 349:1994;125-130.
10. Dahiyat BI, Mayo SL. Probing the role of packing specificity in protein design. Proc Natl Acad Sci USA. 94:1997;10172-10177.
11. Numav N, Kidokoros S. Prediction of the active sites of proteins from amino acid sequences. Biol Pharm Bull. 16:1993;1160-1163.
12. Williamson RM. Information theory analysis of the relationship between primary sequence structure and ligand recognition among a class of facilitated transporters. J Theor Biol. 174:1995;179-188.
13. Lichtarge O, Bourne HR, Cohen FE. An evolutionary trace method defines binding surfaces common to protein families. J Mol Biol. 257:1996;342-358.
14. Cachau RE, Erickson JW, Villar HO. Novel procedure for structure refinement in homology modeling and its application to the human class Mu glutathione S-transferases. Protein Eng. 7:1994;831-839.
15. Rice DW, Eisenberg D. A 3D-1D substitution matrix for protein fold recognition that includes predicted secondary structure of the sequence. J Mol Biol. 267:1997;1026-1038.
16. Dorit RL, Schoenbach L, Gilbert W. How big is the universe of exons? Science. 250:1990;1377-1382.
17. Anchin JM, Mandal C, Culberson C, Subramaniam S, Linthicum DS. Computer-aided molecular modeling of the binding site architecture for eight monoclonal antibodies that bind a high potency guanadinium sweetener. J Mol Graphics. 12:1994;257-266.
18. Koehler RT, Villar HO, Bauer KE, Higgins DL. Ligand based protein alignment and isozyme specificity of glutathione S-transferase inhibitors. Proteins. 28:1997;202-216.
19. Feng ZK, Sippl MJ. Optimum superimposition of protein structures: ambiguities and implications. Fold Des. 1:1996;123-132.
20. Brown RD, Martin YC. Use of structure activity data to compare structure based clustering methods and descriptors for use in compound selection. J Chem Int Comput Sci. 36:1996;572-584.
21. Jackson RC. Update on computer-aided drug design. Curr Opin Biotech. 6:1995;646-651.
22. Shoichet BK, Kuntz ID. Predicting the structure of protein complexes: a step in the right direction. Chem Biol. 3:1996;151-156.
23. Kauvar LM, Higgins DL, Villar HO, Sportsman JR, Engqvist-Goldstein AE, Bukar R, Bauer KE, Dilley H, Rocke DM. Predicting ligand binding to proteins by affinity fingerprinting. Chem & Biol. 2:1995;107-118.
24. Lancet D, Sadovsky E, Seidemann E. Probability model for molecular recognition in biological receptor repertoires: significance to the olfactory system. Proc Natl Acad Sci USA. 90:1993;3715-3719.
25. Kauvar LM, Villar HO, Sportsman JR, Higgins DL, Schmidt DE Jr. Protein affinity map of chemical space. J Chromatogr. 1998.
26. Kauvar LM. Affinity fingerprinting. Pharm Mfr Intl. 8:1995;25-27.
27. Bemis GW, Murcko MA. The properties of known drugs. 1. Molecular frameworks. J Med Chem. 39:1996;2887-2893.
28. McMartin C, Bohacek RS. QXP: powerful, rapid computer algorithms for structure-based drug design. J Comput Aided Mol Des. 11:1997;333-344.
29. Gschwend Da, Good AC, Kuntz ID. Molecular docking towards drug discovery. J Mol Recognit. 9:1996;175-186.
30. Briem H, Kuntz ID. Molecular similarity based on DOCK-generated fingerprints. J Med Chem. 39:1996;3401-3408.
31. Jain AN. Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comp Aided Mol Des. 10:1996;427-440.
32. Patterson DE, Cramer RD, Ferguson AM, Clark RD, Weinberger LE. Neighborhood behavior: a useful concept for validation of 'molecular diversity' descriptors. J Med Chem. 39:1996;3049-3059.
33. Raymer ML, Sanschagrin PC, Punch WF, Venkataraman S, Goodman ED, Kuhn LA. Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm. J Mol Biol. 265:1997;445-464.
34. Lyttle MH. Combinatorial chemistry: a conservative perspective. Drug Dev Res. 35:1995;230-236.
35. Napolitano EW, Villar HO, Higgins DL, Lee SK, Engqvist-Goldstein AE, Bukar R, Calio BL, Roberts D, Jäck HM, Tainer JA. Augmenting recombinant antibody diversity via a Glutathione S-Transferase framework. Chem & Biol. 3:1996;359-367.
36. Lyttle MH, Napolitano EW, Calio BL, Kauvar LM. Mutagenesis using β-cyanoethyl phosphoramidites. Biotechniques. 19:1995;274-281.
37. Murakami M. Critical amino acids responsible for converting specificities of proteins and for enhancing enzyme evolution are located around β-turn potentials: data-based prediction. J Prot Chem. 12:1993;783-789.
38. Borchardt A, Liberles SD, Biggar SR, Crabtree GR, Schreiber SL. Small molecule-dependent genetic selection in stochastic nanodroplets as a means of detecting protein - ligand interactions on a large scale. Chem Biol. 4:1997;961-968.
39. Rejto PA, Verkhivker GM. Unraveling principles of lead discovery: from unfrustrated energy landscapes to novel molecular anchors. Proc Natl Acad Sci USA. 93:1996;8945-8950.
40. Shuker SB, Hajduk PJ, Meadows RP, Fesik SW. Discovering high affinity ligands to proteins: SAR by NMR. Science. 274:1996;1531-1534.
41. Eaton Be, Gold L, Hicke BJ, Janjic N, Jucker FM, Sebesta DP, Tarasow TM, Willis MC, Zichi DA. Post-SELEX combinatorial optimization of aptamers. Bioorg Med Chem. 5:1997;1087-1096.
42. Bhattacharyya DK, Lecomte M, Dunn J, Morgans DJ, Smith WL. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid. Arch Biochem Biophys. 317:1995;19-24.
43. Amin AR, Vyas P, Attur M, Leszczynska-Piziak J, Patel IR, Weissman G, Abramson SB. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA. 92:1993;7926-7930.
44. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. Salicylates inhibit lκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol. 156:1996;3961-3969.
45. Crews CM. Deciphering isozyme function: exploring cell biology with chemistry in the post-genomic era. Chem Biol. 3:1996;961-965.